annual shareholders equity:
$73.85M-$13.89M(-15.83%)Summary
- As of today (September 17, 2025), AVDL annual stockholders equity is $73.85 million, with the most recent change of -$13.89 million (-15.83%) on December 31, 2024.
- During the last 3 years, AVDL annual shareholders equity has fallen by -$4.40 million (-5.62%).
- AVDL annual shareholders equity is now -54.49% below its all-time high of $162.27 million, reached on December 31, 2020.
Performance
AVDL Shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly shareholders equity:
$90.71M+$16.64M(+22.46%)Summary
- As of today (September 17, 2025), AVDL quarterly stockholders equity is $90.71 million, with the most recent change of +$16.64 million (+22.46%) on June 1, 2025.
- Over the past year, AVDL quarterly shareholders equity has increased by +$20.42 million (+29.05%).
- AVDL quarterly shareholders equity is now -50.19% below its all-time high of $182.13 million, reached on June 30, 2020.
Performance
AVDL quarterly shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Shareholders equity Formula
Shareholders Equity = Total Assets − Total Liabilities
AVDL Shareholders equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -15.8% | +29.1% |
| 3 y3 years | -5.6% | +2822.4% |
| 5 y5 years | +352.9% | -50.2% |
AVDL Shareholders equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -15.8% | +449.3% | -36.6% | +337.7% |
| 5 y | 5-year | -54.5% | +352.9% | -50.2% | +337.7% |
| alltime | all time | -54.5% | +352.9% | -50.2% | +337.7% |
AVDL Shareholders equity History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $90.71M(+22.5%) |
| Mar 2025 | - | $74.07M(+0.3%) |
| Dec 2024 | $73.85M(-15.8%) | $73.85M(-1.1%) |
| Sep 2024 | - | $74.66M(+6.2%) |
| Jun 2024 | - | $70.29M(-10.3%) |
| Mar 2024 | - | $78.38M(-10.7%) |
| Dec 2023 | $87.74M(-514.9%) | $87.74M(-20.3%) |
| Sep 2023 | - | $110.15M(-23.1%) |
| Jun 2023 | - | $143.19M(-475.2%) |
| Mar 2023 | - | -$38.17M(+80.5%) |
| Dec 2022 | -$21.14M(-127.0%) | -$21.14M(+70.0%) |
| Sep 2022 | - | -$12.44M(+273.3%) |
| Jun 2022 | - | -$3.33M(-106.0%) |
| Mar 2022 | - | $55.23M(-29.4%) |
| Dec 2021 | $78.24M(-51.8%) | $78.24M(-20.9%) |
| Sep 2021 | - | $98.96M(-16.8%) |
| Jun 2021 | - | $118.88M(-12.9%) |
| Mar 2021 | - | $136.50M(-15.9%) |
| Dec 2020 | $162.27M(-655.7%) | $162.27M(-5.2%) |
| Sep 2020 | - | $171.20M(-6.0%) |
| Jun 2020 | - | $182.13M(+468.0%) |
| Mar 2020 | - | $32.07M(-209.8%) |
| Dec 2019 | -$29.20M(-1150.3%) | -$29.20M(+8.3%) |
| Sep 2019 | - | -$26.96M(+51.7%) |
| Jun 2019 | - | -$17.78M(+85.5%) |
| Mar 2019 | - | -$9.58M(-444.7%) |
| Dec 2018 | $2.78M(-96.8%) | $2.78M(-95.8%) |
| Sep 2018 | - | $65.74M(-16.3%) |
| Jun 2018 | - | $78.55M(-9.8%) |
| Mar 2018 | - | $87.05M(+1.7%) |
| Dec 2017 | $85.58M(+103.4%) | $85.58M(-11.3%) |
| Sep 2017 | - | $96.46M(+25.7%) |
| Jun 2017 | - | $76.73M(+29.9%) |
| Mar 2017 | - | $59.08M(+40.4%) |
| Dec 2016 | $42.07M(-39.1%) | $42.07M(+14.2%) |
| Sep 2016 | - | $36.83M(-28.0%) |
| Jun 2016 | - | $51.15M(-26.6%) |
| Mar 2016 | - | $69.70M(+2.7%) |
| Dec 2015 | $69.13M(+177.7%) | $67.86M(+205.1%) |
| Mar 2015 | - | $22.25M(-10.6%) |
| Dec 2014 | $24.89M(-361.7%) | $24.89M(-37.8%) |
| Sep 2014 | - | $40.05M(-30.8%) |
| Jun 2014 | - | $57.86M(-25.9%) |
| Mar 2014 | - | $78.13M(-921.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2013 | -$9.51M(-131.2%) | -$9.51M(-38.3%) |
| Sep 2013 | - | -$15.40M(+53.1%) |
| Jun 2013 | - | -$10.06M(-146.4%) |
| Mar 2013 | - | $21.68M(-28.9%) |
| Dec 2012 | $30.50M(+2.4%) | $30.50M(+20.3%) |
| Jun 2012 | - | $25.36M(-20.7%) |
| Mar 2012 | - | $31.98M(+7.4%) |
| Dec 2011 | $29.79M(-17.9%) | $29.79M(-7.9%) |
| Sep 2011 | - | $32.36M(+1.5%) |
| Jun 2011 | - | $31.89M(-6.2%) |
| Mar 2011 | - | $34.02M(-6.3%) |
| Dec 2010 | $36.30M(-19.1%) | $36.30M(+8.5%) |
| Sep 2010 | - | $33.47M(-25.4%) |
| Dec 2009 | $44.86M(-7.6%) | $44.86M(-7.6%) |
| Dec 2008 | $48.55M(-11.1%) | $48.55M(-11.1%) |
| Dec 2007 | $54.63M(-25.2%) | $54.63M(-1.5%) |
| Sep 2007 | - | $55.43M(-6.0%) |
| Jun 2007 | - | $58.98M(-13.3%) |
| Mar 2007 | - | $68.02M(-6.9%) |
| Dec 2006 | $73.03M(-15.7%) | $73.03M(-8.0%) |
| Jun 2006 | - | $79.37M(-3.8%) |
| Mar 2006 | - | $82.50M(-4.8%) |
| Dec 2005 | $86.65M(-25.8%) | $86.65M(-8.3%) |
| Sep 2005 | - | $94.53M(-10.1%) |
| Jun 2005 | - | $105.11M(-10.1%) |
| Mar 2005 | - | $116.95M(+0.2%) |
| Dec 2004 | $116.76M(+26.8%) | $116.76M(+19.0%) |
| Sep 2004 | - | $98.09M(+5.7%) |
| Jun 2004 | - | $92.77M(-1.3%) |
| Mar 2004 | - | $94.01M(+2.1%) |
| Dec 2003 | $92.06M(+649.3%) | $92.06M(+349.5%) |
| Sep 2003 | - | $20.48M(+92.5%) |
| Jun 2003 | - | $10.64M(-3.9%) |
| Mar 2003 | - | $11.07M(-9.9%) |
| Dec 2002 | $12.29M(+63.6%) | $12.29M(+2.7%) |
| Sep 2002 | - | $11.96M(+59.2%) |
| Dec 2001 | $7.51M(-31.0%) | $7.51M(-31.0%) |
| Dec 2000 | $10.88M(+20.0%) | $10.88M(+20.0%) |
| Dec 1999 | $9.07M(-49.0%) | $9.07M(-49.0%) |
| Dec 1998 | $17.79M(+24.7%) | $17.79M(+56.0%) |
| Mar 1998 | - | $11.40M(-20.3%) |
| Dec 1997 | $14.26M(-38.3%) | $14.30M(-38.1%) |
| Dec 1996 | $23.10M | $23.10M(-1640.0%) |
| Mar 1996 | - | -$1.50M |
FAQ
- What is Avadel Pharmaceuticals plc annual stockholders equity?
- What is the all time high annual shareholders equity for Avadel Pharmaceuticals plc?
- What is Avadel Pharmaceuticals plc annual shareholders equity year-on-year change?
- What is Avadel Pharmaceuticals plc quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Avadel Pharmaceuticals plc?
- What is Avadel Pharmaceuticals plc quarterly shareholders equity year-on-year change?
What is Avadel Pharmaceuticals plc annual stockholders equity?
The current annual shareholders equity of AVDL is $73.85M
What is the all time high annual shareholders equity for Avadel Pharmaceuticals plc?
Avadel Pharmaceuticals plc all-time high annual stockholders equity is $162.27M
What is Avadel Pharmaceuticals plc annual shareholders equity year-on-year change?
Over the past year, AVDL annual stockholders equity has changed by -$13.89M (-15.83%)
What is Avadel Pharmaceuticals plc quarterly stockholders equity?
The current quarterly shareholders equity of AVDL is $90.71M
What is the all time high quarterly shareholders equity for Avadel Pharmaceuticals plc?
Avadel Pharmaceuticals plc all-time high quarterly stockholders equity is $182.13M
What is Avadel Pharmaceuticals plc quarterly shareholders equity year-on-year change?
Over the past year, AVDL quarterly stockholders equity has changed by +$20.42M (+29.05%)